Wei He

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Signal transduction and targeted therapy

Expert opinion on drug delivery

AAPS PharmSciTech

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He
Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Kosheli Thapa Magar, Hamza Boucetta, Zongmin Zhao, Ying Xu, Zhengxia Liu, Wei He
Injectable long-acting formulations (ILAFs) and manufacturing techniques. Expert opinion on drug delivery 21 (6) (2024)
Kosheli Thapa Magar, Hamza Boucetta, Zongmin Zhao, Ying Xu, Zhengxia Liu, Wei He
Injectable long-acting formulations (ILAFs) and manufacturing techniques. Expert opinion on drug delivery (2024)
Kosheli Thapa Magar, Hamza Boucetta, Zongmin Zhao, Ying Xu, Zhengxia Liu, Wei He
Injectable long-acting formulations (ILAFs) and manufacturing techniques. Expert opinion on drug delivery (2024)
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He
Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He
Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, George Frimpong Boafo, Kosheli Thapa Magar, Yanmin Ju, Wei He
Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Mingyang Ma, Huiling Zeng, Pei Yang, Jiabing Xu, Xingwang Zhang, Wei He
Drug Delivery and Therapy Strategies for Osteoporosis Intervention. Molecules (Basel, Switzerland) 28 (18) (2023)
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng, Wei He
Approved Nanomedicine against Diseases. Pharmaceutics 15 (3) (2023)
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng, Wei He
Approved Nanomedicine against Diseases. Pharmaceutics 15 (3) (2023)
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng, Wei He
Approved Nanomedicine against Diseases. Pharmaceutics 15 (3) (2023)
Ying Wang, Siyuan Xu, Ziyue Xiao, Yuxin Jiang, Qi Jiang, Jun Li, Wei He
Stiripentol Enteric Solid Dispersion-Loaded Effervescent Tablets: Enhanced Dissolution, Stability, and Absorption. AAPS PharmSciTech 23 (5) (2022)
Makhloufi Zoulikha, Wei He
Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharmaceutical research 39 (3) (2022)
Feifei Huang, Xiaohong Jiang, Marwa A Sallam, Xingwang Zhang, Wei He
A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization. AAPS PharmSciTech 23 (3) (2022)
Wei He, Annie Turkeshi, Xiaotong Li, Hongwei Zhang
Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles. Therapeutic delivery 11 (9) (2020)
Imran Shair Mohammad, Birendra Chaurasiya, Xuan Yang, Chuchu Lin, Hehui Rong, Wei He
Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells. Pharmaceutics 12 (10) (2020)
Yaqi Lyu, Qingqing Xiao, Lifang Yin, Lei Yang, Wei He
Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis. Signal transduction and targeted therapy 4 (1) (2019)
Yaqi Lyu, Qingqing Xiao, Lifang Yin, Lei Yang, Wei He
Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis. Signal transduction and targeted therapy 4 (2019)
Yaqi Lyu, Qingqing Xiao, Yi Li, Yubing Wu, Wei He, Lifang Yin
"Locked" cancer cells are more sensitive to chemotherapy. Bioengineering & translational medicine 4 (2) (2019)
Yaqi Lv, Chaoran Xu, Xiangmei Zhao, Chenshi Lin, Xin Yang, Xiaofei Xin, Li Zhang, Chao Qin, Xiaopeng Han, Lei Yang, Wei He, Lifang Yin
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. ACS nano 12 (2) (2018)